Carvedilol Suppresses Intractable Hiccups

References

1. ↵
   Hansen BJ, Rosenberg J. Persistent postoperative hiccups: a review. Acta Anaesthesiol Scand 1993; 37: 643–6.

   OpenUrlPubMed
2. ↵
   Miyaoka H, Kamijima K. Perphenazine-induced hiccups. Pharmacopsychiatry 1999; 32: 81.

   OpenUrlPubMed
3. ↵
   Lierz P, Felleiter P. Anesthesia as therapy for persistent hiccups. Anesth Analg 2002; 95: 494–5.

   OpenUrlPubMedWeb of Science
4. ↵
   Swartz CM. Tardive psychopathology. Neuropsychobiology 1995; 32: 115–9.

   OpenUrlPubMedWeb of Science
5. ↵
   Lader M. Beta-adrenoceptor antagonists in neuropsychiatry: an update. J Clin Psychiatry 1988; 49: 213–23.

   OpenUrlPubMedWeb of Science
6. ↵
   Donohue P. Medicine can end hiccups when remedies fail. St. Augustine Record, 2005 July 20; Health Watch.
7. ↵
   Malcolm K. Supersensitivity psychosis with concurrent episodic vomiting. Br J Psychiatry 1992; 161: 407–9.

   OpenUrlAbstract/FREE Full Text
8. ↵
   Woerner MG, Alvir JM, Saltz BL, Lieberman JA, Kane JM. Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Am J Psychiatry 1998; 155: 1521–8.

   OpenUrlPubMedWeb of Science
9. ↵
   Kropp S, Kern V, Lange K, et al. Oxidative stress during treatment with first- and second-generation antipsychotics. J Neuropsychiatry Clin Neurosci 2005; 17: 227–31.

   OpenUrlPubMed
10. ↵
    Swartz CM, inventor. Administration of carvedilol to mitigate tardive movement disorders, psychosis, mania, and depression. United States patent 6,365,618. Issued 2002 Apr 2.
11. ↵
    Naidu PS, Singh A, Kulkarni SK. Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms. Br J Pharmacology 2002; 136: 193–200.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    Dulin B, Abraham WT. Pharmacology of carvedilol. Am J Cardiology 2004; 93(9A): 3B–6B.

    OpenUrl
13. ↵
    Swartz CM. Betaxolol in anxiety disorders. Ann Clin Psychiatry 1998; 10: 9–14.

    OpenUrlPubMed